<!DOCTYPE html><html><head><link href='https://fonts.googleapis.com/css?family=Spectral' rel='stylesheet'><style>body {    font-family: 'Spectral';font-size: 14px;}</style></head><body><b>Search Term: </b>"hematopoietic stem cells" AND CRISPR AND AAV AND ("sickle cell disease" OR "beta thalassemia")<br><b>Date run: </b>2020/01/05<br><br><h2>PubMed Articles</h2> <br><br><b><a href="https://ncbi.nlm.nih.gov/pubmed/31658261">Prediction of off-target specificity and cell-specific fitness of CRISPR-Cas System using attention boosted deep learning and network-based gene feature.</a></b><br><b>Journal:</b> PLoS Comput. Biol.<br><b>Two-year IF:</b> 4.38<br><br><b><a href="https://ncbi.nlm.nih.gov/pubmed/31763350">Immunoresponse to Gene-Modified Hematopoietic Stem Cells.</a></b><br><b>Journal:</b> Mol Ther Methods Clin Dev<br><b>Two-year IF:</b> 3.64<br><br><b><a href="https://ncbi.nlm.nih.gov/pubmed/31608113">Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders.</a></b><br><b>Journal:</b> Front Genet<br><b>Two-year IF:</b> 3.36<br><br><b><a href="http://google.com">More Results...</a></b><br><br><h2>Companies</h2> <br><br><b><a href="https://www.linkedin.com/company/crispr-therapeutics/about/">CRISPR Therapeutics</a></b><br><br><b><a href="https://www.linkedin.com/company/orchard-therapeutics/about/">Orchard Therapeutics</a></b><br><br><b><a href="https://www.linkedin.com/company/trucode-gene-repair-inc/about/">Trucode Gene Repair, Inc.</a></b><br><br><b><a href="http://google.com">More Results...</a></b><br><br><h2>Patents</h2> <br><br><b><a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5&p=1&f=G&l=50&d=PTXT&S1=(((%22hematopoietic+stem+cells%22+AND+CRISPR)+AND+AAV)+AND+(%22sickle+cell+disease%22+OR+%22beta+thalassemia%22))&OS="hematopoietic+stem+cells"+AND+CRISPR+AND+AAV+AND+("sickle+cell+disease"+OR+"beta+thalassemia")&RS=((("hematopoietic+stem+cells"+AND+CRISPR)+AND+AAV)+AND+("sickle+cell+disease"+OR+"beta+thalassemia"))">Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription</a></b><br><b>Patent date:</b> November 26, 2019<br><br><b><a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=1&p=1&f=G&l=50&d=PTXT&S1=(((%22hematopoietic+stem+cells%22+AND+CRISPR)+AND+AAV)+AND+(%22sickle+cell+disease%22+OR+%22beta+thalassemia%22))&OS="hematopoietic+stem+cells"+AND+CRISPR+AND+AAV+AND+("sickle+cell+disease"+OR+"beta+thalassemia")&RS=((("hematopoietic+stem+cells"+AND+CRISPR)+AND+AAV)+AND+("sickle+cell+disease"+OR+"beta+thalassemia"))">Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription</a></b><br><b>Patent date:</b> December 31, 2019<br><br><b><a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=2&p=1&f=G&l=50&d=PTXT&S1=(((%22hematopoietic+stem+cells%22+AND+CRISPR)+AND+AAV)+AND+(%22sickle+cell+disease%22+OR+%22beta+thalassemia%22))&OS="hematopoietic+stem+cells"+AND+CRISPR+AND+AAV+AND+("sickle+cell+disease"+OR+"beta+thalassemia")&RS=((("hematopoietic+stem+cells"+AND+CRISPR)+AND+AAV)+AND+("sickle+cell+disease"+OR+"beta+thalassemia"))">Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription</a></b><br><b>Patent date:</b> December 24, 2019<br><br><b><a href="http://google.com">More Results...</a></b><br><br><br><b><a href="http://google.com">Link to Full Search Results</a></b><br></body></html>